23 January 2020 (Thursday) - Bcr-Abl tyrosine-kinase inhibitors
The subject of Bcr-Abl tyrosine-kinase inhibitors came up at work today. I’m not going to pretend that I had the faintest idea, so I looked it up. As always Wikipedia gave the most concise description to the layman.
I won’t pretend that I understood it all, but I understand more than I did, and (as I always say) a day when you learn nothing is a day wasted…
Labels: clinical condition